- Home
- FSEA vs ABVC Comparison
FSEA vs ABVC Comparison
Compare FSEA & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- ABVC
- Stock Information
- Founded
- FSEA 1890
- ABVC 2015
- Country
- FSEA United States
- ABVC United States
- Employees
- FSEA N/A
- ABVC N/A
- Industry
- FSEA Savings Institutions
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- FSEA Finance
- ABVC Health Care
- Exchange
- FSEA Nasdaq
- ABVC Nasdaq
- Market Cap
- FSEA 53.7M
- ABVC 52.1M
- IPO Year
- FSEA N/A
- ABVC N/A
- Fundamental
- Price
- FSEA $11.21
- ABVC $3.30
- Analyst Decision
- FSEA
- ABVC
- Analyst Count
- FSEA 0
- ABVC 0
- Target Price
- FSEA N/A
- ABVC N/A
- AVG Volume (30 Days)
- FSEA 4.5K
- ABVC 223.6K
- Earning Date
- FSEA 08-08-2025
- ABVC 08-13-2025
- Dividend Yield
- FSEA N/A
- ABVC N/A
- EPS Growth
- FSEA N/A
- ABVC N/A
- EPS
- FSEA N/A
- ABVC N/A
- Revenue
- FSEA $14,095,000.00
- ABVC $391,242.00
- Revenue This Year
- FSEA N/A
- ABVC $735.18
- Revenue Next Year
- FSEA N/A
- ABVC N/A
- P/E Ratio
- FSEA N/A
- ABVC N/A
- Revenue Growth
- FSEA 30.26
- ABVC 186.84
- 52 Week Low
- FSEA $8.90
- ABVC $0.40
- 52 Week High
- FSEA $11.80
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- FSEA 43.66
- ABVC 56.53
- Support Level
- FSEA $10.13
- ABVC $2.90
- Resistance Level
- FSEA $11.48
- ABVC $3.06
- Average True Range (ATR)
- FSEA 0.18
- ABVC 0.28
- MACD
- FSEA -0.03
- ABVC 0.00
- Stochastic Oscillator
- FSEA 69.53
- ABVC 91.92
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.